rs1553939675
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The ENST00000381431.10(SGCB):c.859del(p.Leu287SerfsTer14) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L287L) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Consequence
SGCB
ENST00000381431.10 frameshift
ENST00000381431.10 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.75
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.102 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.859del | p.Leu287SerfsTer14 | frameshift_variant | 6/6 | ENST00000381431.10 | NP_000223.1 | |
SGCB | XM_047416074.1 | c.649del | p.Leu217SerfsTer14 | frameshift_variant | 5/5 | XP_047272030.1 | ||
SGCB | XM_047416075.1 | c.562del | p.Leu188SerfsTer14 | frameshift_variant | 5/5 | XP_047272031.1 | ||
SGCB | XM_047416076.1 | c.562del | p.Leu188SerfsTer14 | frameshift_variant | 5/5 | XP_047272032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.859del | p.Leu287SerfsTer14 | frameshift_variant | 6/6 | 1 | NM_000232.5 | ENSP00000370839 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 16, 2017 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with SGCB-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the SGCB gene (p.Leu287Serfs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 32 amino acids of the SGCB protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at